Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Urinary Glycolic Acid Predicts Kidney Function Decline in Type 1 Diabetic Subjects

    Darshi, M., Kim, J. J., Ahluwalia, T. S., Rossing, Peter, Groop, P. & Sharma, K., 2019, In: Journal of the American Society of Nephrology. 30, Kidney Week Edition, 1 p., TH-PO919.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  2. Published

    Urine Metabolites Predict Kidney Function Decline in Type I Diabetic Subjects

    Darshi, M., Valo, E., Zhang, J., Kim, J. J., Saito, R., Montemayor, D., Ahluwalia, T. S., Snell-Bergeon, J., Rossing, Peter, Groop, P., Natarajan, L. & Sharma, K., 2018, In: Journal of the American Society of Nephrology. 29, Abstract Supplement, p. 539 1 p.

    Research output: Contribution to journalConference abstract in journalResearch

  3. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, Peter, Tsapas, A., Wexler, D. J. & Buse, J. B., 2018, In: Diabetes Care. 41, 12, p. 2669-2701 33 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, Peter, Tsapas, A., Wexler, D. J. & Buse, J. B., 2018, In: Diabetologia. 61, 12, p. 2461-2498 38 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): A randomized clinical trial

    Davies, M. J., Bain, S. C., Atkin, S. L., Rossing, Peter, Scott, D., Shamkhalova, M. S., Bosch-Traberg, H., Syrén, A. & Umpierrez, G. E., Feb 2016, In: Diabetes Care. 39, 2, p. 222-230 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetes Care. 45, 11, p. 2753-2786 34 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetologia. 65, 12, p. 1925-1966 42 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Serum urate lowering with allopurinol and kidney function in type 1 diabetes

    Doria, A., Galecki, A. T., Spino, C., Pop-Busui, R., Cherney, D. Z., Lingvay, I., Parsa, A., Rossing, P., Sigal, R. J., Afkarian, M., Aronson, R., Caramori, M. L., Crandall, J. P., De Boer, I. H., Elliott, T. G., Goldfine, A. B., Haw, J. S., Hirsch, I. B., Karger, A. B., Maahs, D. M. & 14 others, McGill, J. B., Molitch, M. E., Perkins, B. A., Polsky, S., Pragnell, M., Robiner, W. N., Rosas, S. E., Senior, P., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Weinstock, R. S., Wu, C. & Mauer, M., 2020, In: New England Journal of Medicine. 382, 26, p. 2493-2503 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance

    Ebert, T., Anker, S. D., Ruilope, L. M., Fioretto, P., Fonseca, V., Umpierrez, G. E., Birkenfeld, A. L., Lawatscheck, R., Scott, C., Rohwedder, K., Rossing, Peter & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2024, In: Diabetes Care. 47, 3, p. 362–370 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics

    Eder, S., Leierer, J., Kerschbaum, J., Rosivall, L., Wiecek, A., de Zeeuw, D., Mark, P. B., Heinze, G., Rossing, Peter, Heerspink, H. L. & Mayer, G., 2018, In: Kidney and Blood Pressure Research. 43, 1, p. 181-190

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries

    Eder, S., Leierer, J., Kerschbaum, J., Rosivall, L., Wiecek, A., de Zeeuw, D., Mark, P. B., Heinze, G., Rossing, Peter, Heerspink, H. L. & Mayer, G., 2019, In: Diabetes and Vascular Disease Research. 16, 1, p. 47-56

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors

    Eickhoff, M. K., Dekkers, C. C. J., Kramers, B. J., Laverman, G. D., Frimodt-Møller, M., Jørgensen, Niklas Rye, Faber, Jens, Danser, A. H. J., Gansevoort, R. T., Rossing, Peter, Persson, F. & Heerspink, H. J. L., 31 May 2019, In: Journal of Clinical Medicine. 8, 6

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria: A double blind randomized placebo-controlled crossover trial

    Eickhoff, M. K., Olsen, F. J., Frimodt-Møller, M., Diaz, L. J., Faber, Jens, Jensen, M. T., Rossing, Peter & Persson, F., 2020, In: Journal of Diabetes and its Complications. 34, 7, 7 p., 107590.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions

    Eickhoff, M. K., Winther, S. A., Hansen, T. W., Diaz, L. J., Persson, F., Rossing, Peter & Frimodt-Møller, M., Dec 2020, In: PLoS ONE. 15, e0243737.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

    Ertuglu, L. A., Porrini, E., Hornum, Mads, Demiray, A., Afsar, B., Ortiz, A., Covic, A., Rossing, Peter & Kanbay, M., 2021, In: Transplant International. 34, 8, p. 1341-1359 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus

    Fauchier, L., Boriani, G., De Groot, J. R., Kreutz, R., Rossing, Peter & Camm, A. J., 2021, In: Europace. 23, 12, p. 1873-1891 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  18. Published

    Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort

    Ferreira, I., Hovind, P., Schalkwijk, C. G., Parving, H. H., Stehouwer, C. D. A. & Rossing, Peter, 2018, In: Diabetologia. 61, 1, p. 231-241 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Ferreira-Divino, L. F., Suvitaival, T., Curovic, V. R., Tofte, N., Trošt, K., Mattila, I. M., Theilade, Karen Simone, Winther, S. A., Hansen, T. W., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, Peter, 2022, In: Cardiovascular Diabetology. 21, 10 p., 135.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes

    Filippatos, G., Anker, S. D., Pitt, B., Rossing, Peter, Joseph, A., Kolkhof, P., Lambelet, M., Lawatscheck, R., Bakris, G. L., Ruilope, L. M. & Agarwal, R., 2022, In: JACC: Heart Failure. 10, 11, p. 860-870 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial

    Filippatos, G., Pitt, B., Agarwal, R., Farmakis, D., Ruilope, L. M., Rossing, Peter, Bauersachs, J., Mentz, R. J., Kolkhof, P., Scott, C., Joseph, A., Bakris, G. L., Anker, S. D. & FIDELIO-DKD Investigators, F. I., 2022, In: European Journal of Heart Failure. 24, 6, p. 996-1005 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

    FIDELIO-DKD Investigators, F. I., 2021, In: Circulation. 143, 6, p. 540-552 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes

    Filippatos, G. & FIDELIO-DKD Investigators, F. I., 2021, In: Journal of the American College of Cardiology. 78, 2, p. 142-152 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 12937790